GEODE CAPITAL MANAGEMENT, LLC - EPIZYME INC ownership

EPIZYME INC's ticker is EPZM and the CUSIP is 29428V104. A total of 96 filers reported holding EPIZYME INC in Q2 2022. The put-call ratio across all filers is 5.75 and the average weighting 0.3%.

Quarter-by-quarter ownership
GEODE CAPITAL MANAGEMENT, LLC ownership history of EPIZYME INC
ValueSharesWeighting
Q2 2022$2,232,000
-18.6%
1,518,496
-36.3%
0.00%
Q1 2022$2,741,000
-33.9%
2,383,960
+43.7%
0.00%
Q4 2021$4,147,000
-52.2%
1,658,936
-2.0%
0.00%
-100.0%
Q3 2021$8,670,000
-36.4%
1,693,517
+3.2%
0.00%
-50.0%
Q2 2021$13,640,000
-1.6%
1,641,492
+3.2%
0.00%0.0%
Q1 2021$13,858,000
-11.2%
1,591,060
+10.7%
0.00%
-33.3%
Q4 2020$15,612,000
-3.5%
1,437,596
+6.0%
0.00%0.0%
Q3 2020$16,176,000
-22.6%
1,355,979
+4.2%
0.00%
-25.0%
Q2 2020$20,897,000
+15.8%
1,301,243
+11.8%
0.00%
-20.0%
Q1 2020$18,049,000
-65.5%
1,163,792
-45.3%
0.01%0.0%
Q4 2019$52,330,000
+408.4%
2,127,280
+113.2%
0.01%
+150.0%
Q3 2019$10,294,000
-14.3%
998,001
+4.2%
0.00%
-33.3%
Q2 2019$12,018,000
+18.3%
957,672
+16.8%
0.00%0.0%
Q1 2019$10,159,000
+24.2%
819,955
-38.3%
0.00%
+200.0%
Q4 2018$8,182,000
+42.5%
1,328,556
+145.2%
0.00%
-50.0%
Q3 2018$5,743,000
-17.4%
541,821
+5.6%
0.00%0.0%
Q2 2018$6,951,000
-18.0%
513,029
+7.4%
0.00%
-33.3%
Q1 2018$8,481,000
+50.3%
477,843
+6.3%
0.00%
+50.0%
Q4 2017$5,642,000
-37.1%
449,579
-4.5%
0.00%
-33.3%
Q3 2017$8,963,000
+67.9%
470,541
+33.1%
0.00%
+50.0%
Q2 2017$5,338,000
-7.8%
353,514
+4.7%
0.00%0.0%
Q1 2017$5,792,000
+48.5%
337,747
+4.7%
0.00%0.0%
Q4 2016$3,901,000
+34.1%
322,448
+9.0%
0.00%
+100.0%
Q3 2016$2,910,000
-5.6%
295,821
-1.8%
0.00%
-50.0%
Q2 2016$3,084,000
-6.6%
301,224
+10.6%
0.00%0.0%
Q1 2016$3,301,000
+25.2%
272,389
+65.4%
0.00%0.0%
Q4 2015$2,637,000
+26.2%
164,686
+1.4%
0.00%
+100.0%
Q3 2015$2,089,000
-45.5%
162,452
+1.7%
0.00%
-50.0%
Q2 2015$3,834,000
+50.6%
159,767
+17.9%
0.00%
+100.0%
Q1 2015$2,545,000
+58.6%
135,544
+59.3%
0.00%0.0%
Q4 2014$1,605,000
-33.5%
85,105
-4.4%
0.00%
-50.0%
Q3 2014$2,412,000
+3.3%
88,979
+18.5%
0.00%0.0%
Q2 2014$2,336,000
+45.6%
75,082
+6.6%
0.00%
+100.0%
Q1 2014$1,604,000
+177.0%
70,452
+153.1%
0.00%
Q4 2013$579,000
-47.2%
27,838
+1.9%
0.00%
-100.0%
Q3 2013$1,097,000
+53.6%
27,330
+7.7%
0.00%0.0%
Q2 2013$714,00025,3750.00%
Other shareholders
EPIZYME INC shareholders Q2 2022
NameSharesValueWeighting ↓
TUDOR INVESTMENT CORP ET AL 218,384$4,0000.00%
View complete list of EPIZYME INC shareholders